Results 151 to 160 of about 65,436 (336)

Optic neuropathy in iron overload and iron chelation therapy [PDF]

, 2022
Samyuktha Melachuri, Chelsey Chaehee Lim, Jacob Winters   +2 more
openalex   +1 more source

Photocatalytic Asymmetric C‐C Coupling for CO2 Reduction on Cu‐Zn Bimetallic Catalysts with Dipole‐Limiting Effects

Advanced Science, EarlyView.
Asymmetric Cu–Zn dual sites on EDTA‐grafted Ti‐MOF amplify the dipole‐limiting domain field (DLDF), facilitating C–C coupling. This strategy yields an exceptional C2H4 production rate of 308.72 µmol g−1 h−1 with 98.4% electron selectivity in photocatalytic CO2 reduction, highlighting the potential of asymmetric site engineering and local field ...
Peidong Ma, Ying Yu, Fan Wen, Hongyan Guo, Boyu Li, GuoZhi Deng, Xianyang Shi, Daochuan Jiang, Ruting Huang   +8 more
wiley   +1 more source

Iron Chelation Suppresses Ferritin Upregulation and Attenuates Vascular Dysfunction in the Aorta of Angiotensin II–Infused Rats [PDF]

, 2005
Nobukazu Ishizaka, Kan Saito, Ichiro Mori, Gen Matsuzaki, Minoru Ohno, Ryozo Nagai   +5 more
openalex   +1 more source

Iron chelating drugs [PDF]

BMJ, 1988
openaire   +2 more sources

Modulation of Electronic Structure in Kraft Lignin‐Derived Mo Single‐Atom Catalysts for Optimized Electrochemical Oxygen Reduction

Advanced Science, EarlyView.
Biomass‐derived lignin is used as a sustainable precursor to synthesize Mo single atoms anchored on a nitrogen‐coordinated carbon framework. As the Mo structure transitions from MoC clusters to isolated single‐atom sites, oxygen evolution reaction (ORR) activity progressively improves.
Junbeom Park, Jaemin Park, Jun Ho Seok, Ji Soo Byun, Cheoulwoo Oh, Eung‐Dab Kim, Young‐Jin Ko, Youngeun Kim, Gawon Sim, Min Jae Kim, Hyeon‐Seok Bang, Ho Seok Park, Chun‐Jae Yoo, Sang Uck Lee, Hyung‐Suk Oh, Kwang Ho Kim, Wooseok Yang   +16 more
wiley   +1 more source

Application of Fuzzy AHP for Medication Decision Making in Iron-Chelating Medications for Thalassemia

Pharmacy
Iron overload is a significant concern for patients with thalassemia and often necessitates the use of iron-chelating agents to mitigate the associated complications.
Saeed Barzegari, Hosein Rostamian, Ehsan Firoozi-Majd, Ibrahim Arpaci   +3 more
doaj   +1 more source

Iron chelation therapy in the myelodysplastic syndromes and aplastic anemia: a review of experience in South Korea [PDF]

, 2008
Jong Wook Lee
openalex   +1 more source

A Universal Metal–Flavonoid Coating Strategy: Engineering Biomaterials for Diabetic Bone Regeneration

Advanced Science, EarlyView.
Construction of metal–flavonoid functionalized coatings on conventional bone repair materials. A one‐pot method is used to directly construct multifunctional metal–flavonoid coatings on the surface of traditional bone repair materials by selecting metal ions with osteogenic/angiogenic properties and flavonoids with reactive oxygen species scavenging ...
Chen Yang, Chenle Dong, Lefeng Su, Zhiqiang Liu, Lingyi Hu, Qishu Jin, Hao Chen, Chunlong Zhang, Yihao Wu, Jiang Chang, Zhaowenbin Zhang, Jiandong Yuan   +11 more
wiley   +1 more source

Iron chelation improves ineffective erythropoiesis and iron overload in myelodysplastic syndrome mice. [PDF]

Elife, 2023
An W, Feola M, Levy M, Aluri S, Ruiz-Martinez M, Sridharan A, Fibach E, Zhu X, Verma A, Ginzburg Y.   +9 more
europepmc   +1 more source

Aqueous Zinc‐Based Batteries: Active Materials, Device Design, and Future Perspectives

Advanced Energy Materials, EarlyView.
This review conducts a comprehensive analysis of aqueous zinc‐based batteries (AZBs) based on their intrinsic mechanisms, including redox reactions, ion intercalation reactions, alloying reactions, electrochemical double‐layer reactions, and mixed mechanisms, systematically discussing recent advancements in each type of AZBs.
Yan Ran, Fang Dong, Shuhui Sun, Yong Lei
wiley   +1 more source